Tymms KE - Search Results

1

Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.

Tymms KE, Beller EM, Webb J, Schrieber L, Buchanan WW. Tymms KE, et al. Clin Rheumatol. 1990 Dec;9(4):523-9. doi: 10.1007/BF02030515. Clin Rheumatol. 1990. PMID: 2088650

2

Treatment of collagenous colitis with methotrexate.

Bhullar DS, Tymms KE, Hillman L, Jain S. Bhullar DS, et al. Among authors: tymms ke. Aust N Z J Med. 1996 Feb;26(1):114. doi: 10.1111/j.1445-5994.1996.tb02918.x. Aust N Z J Med. 1996. PMID: 8775540 No abstract available.

3

Polydermatomyositis with anti-PL7 antibody: clinical and laboratory follow-up over a five year period.

Walker EJ, Jeffrey PD, Webb J, Tymms KE. Walker EJ, et al. Among authors: tymms ke. Clin Exp Rheumatol. 1989 Sep-Oct;7(5):537-40. Clin Exp Rheumatol. 1989. PMID: 2591129

4

Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.

Walker EJ, Tymms KE, Webb J, Jeffrey PD. Walker EJ, et al. Among authors: tymms ke. J Immunol Methods. 1987 Feb 11;96(2):149-56. doi: 10.1016/0022-1759(87)90308-5. J Immunol Methods. 1987. PMID: 3100649

5

Dermatopolymyositis and other connective tissue diseases: a review of 105 cases.

Tymms KE, Webb J. Tymms KE, et al. J Rheumatol. 1985 Dec;12(6):1140-8. J Rheumatol. 1985. PMID: 4093921

6

Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis.

Hoa S, Bernatsky S, Baron M, Proudman S, Stevens W, Sahhar J, Wang M, Steele RJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Nikpour M, Hudson M. Hoa S, et al. Chest. 2021 Dec;160(6):2158-2162. doi: 10.1016/j.chest.2021.06.014. Epub 2021 Jun 18. Chest. 2021. PMID: 34153341 No abstract available.

7

The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.

Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G. Bird P, et al. J Rheumatol. 2013 Mar;40(3):228-35. doi: 10.3899/jrheum.120922. Epub 2013 Jan 15. J Rheumatol. 2013. PMID: 23322457

8

Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group.

Kelly A, Bartlett SJ, de Wit MP, Beaton DE, Dawson T, Evans V, Gill M, Hassett G, March L, Scholte-Voshaar M, Singh JA, Tong A, Tugwell P, Wong P, Tymms K. Kelly A, et al. J Rheumatol. 2019 Sep;46(9):1202-1206. doi: 10.3899/jrheum.181078. Epub 2019 Jan 15. J Rheumatol. 2019. PMID: 30647162

9

Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review.

Kelly A, Crimston-Smith L, Tong A, Bartlett SJ, Bekker CL, Christensen R, De Vera MA, de Wit M, Evans V, Gill M, March L, Manera K, Nieuwlaat R, Salmasi S, Scholte-Voshaar M, Singh JA, Sumpton D, Toupin-April K, Tugwell P, van den Bemt B, Verstappen S, Tymms K. Kelly A, et al. J Rheumatol. 2020 Oct 1;47(10):1565-1574. doi: 10.3899/jrheum.190726. Epub 2019 Dec 15. J Rheumatol. 2020. PMID: 31839595

10

Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study.

Bekker CL, Bossina S, de Vera MA, Bartlett SJ, de Wit M, March L, Shea B, Evans V, Richards D, Tong A, Tugwell P, Tymms K, Scholte-Voshaar M, Kelly A, van den Bemt BJF. Bekker CL, et al. J Rheumatol. 2021 Sep;48(9):1480-1487. doi: 10.3899/jrheum.201568. Epub 2021 May 15. J Rheumatol. 2021. PMID: 33993113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page